Guarda Angela S
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Physiol Behav. 2008 Apr 22;94(1):113-20. doi: 10.1016/j.physbeh.2007.11.020. Epub 2007 Nov 22.
Anorexia nervosa is a behavioral disorder characterized by ego-syntonic self-starvation, denial of illness and ambivalence towards treatment. Treatment refusal and drop-out rates are high and relapse is common. Treatment is best viewed as comprised of two phases, weight restoration and normalization of eating behavior followed by relapse prevention. Most patients verbalize a desire to change, however they seek treatment on their own terms, ideally with minimal or no weight gain. Successful treatment must therefore convince patients to overcome their drive to diet. Evidence-based data on treatment interventions for anorexia nervosa are scarce and methodological problems afflict the few published, controlled trials. Taken together, clinical expertise and data from correlational and controlled trials suggest that chronicity and adult status are associated with a worse prognosis. Outpatient family therapy is effective in weight-restoring the majority of adolescent patients whereas older patients, or those with severe medical or psychiatric comorbidity, often require intensive treatment on an inpatient eating disorders behavioral specialty unit. Correlational data suggest that weight-restored patients are less likely to relapse. Despite limitations of the current knowledge-base, several new areas of research hold promise in elucidating risk factors, in identifying the pathophysiology that sustains anorectic behavior, and in developing more targeted and effective treatments.
神经性厌食症是一种行为障碍,其特征为自我和谐的自我饥饿、否认疾病以及对治疗的矛盾态度。治疗拒绝率和退出率很高,复发很常见。治疗最好被视为包括两个阶段,即体重恢复和饮食行为正常化,随后是预防复发。大多数患者表示有改变的愿望,然而他们按照自己的条件寻求治疗,理想情况下体重增加很少或没有增加。因此,成功的治疗必须说服患者克服节食的冲动。关于神经性厌食症治疗干预的循证数据稀缺,少数已发表的对照试验存在方法学问题。综合来看,临床专业知识以及来自相关性和对照试验的数据表明,病程长和成年状态与较差的预后相关。门诊家庭治疗对大多数青少年患者恢复体重有效,而年龄较大的患者或有严重医学或精神共病的患者通常需要在住院饮食失调行为专科病房接受强化治疗。相关性数据表明,体重恢复的患者复发的可能性较小。尽管目前的知识库存在局限性,但几个新的研究领域有望阐明危险因素、确定维持厌食行为的病理生理学,并开发更有针对性和更有效的治疗方法。